← Back to headlines
Morgan Stanley Raises BioNTech SE Price Target
Morgan Stanley has slightly raised its price target for BioNTech SE (BNTX) as it updates its biopharma coverage models.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
